Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
Clinical trial NCT05842954 · COMPLETED
Trial details
- NCT number
- NCT05842954
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-07
- Primary completion
- 2025-06-27
- Enrollment
- 1720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.